About ValenTx
ValenTx is a company based in Carpinteria (United States) founded in 2002. It operates as a B2B. ValenTx has raised $48.74 million across 5 funding rounds from investors including Medtronic, EDF Ventures and Kaiser Permanente Ventures. ValenTx operates in a competitive market with competitors including GI Windows, Hangzhou Tongee Medical Technology, BariaTek, EndObetes and Keyron, among others.
- Headquarter Carpinteria, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$48.74 M (USD)
in 5 rounds
-
Latest Funding Round
$1.97 M (USD), Series B
Feb 19, 2019
-
Investors
Medtronic
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ValenTx
ValenTx has successfully raised a total of $48.74M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $1.97 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ValenTx
ValenTx has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, EDF Ventures and Kaiser Permanente Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage US tech and life science companies are invested in.
|
Locked | Locked | Locked | |
|
Tech and Life Sciences focused corporate VC firm investing in the US
|
Locked | Locked | Locked | |
|
Venture capital fund focused on early-stage healthcare startups
|
Locked | Locked | Locked |
Investor details for ValenTx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ValenTx
Investment portfolio details for ValenTx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ValenTx
Detailed financials for ValenTx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Valentx Comparisons
Peer comparison for ValenTx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ValenTx
ValenTx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GI Windows, Hangzhou Tongee Medical Technology, BariaTek, EndObetes and Keyron, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nonsurgical endoscopic devices for GI tract anastomoses are developed.
|
|
| Locked | Locked | Locked |
Medical technology solutions are developed in Hangzhou, China.
|
|
| Locked | Locked | Locked |
Minimally invasive devices for obesity treatment are developed endoscopically.
|
|
| Locked | Locked | Locked |
Surgical access tool for obesity and diabetes treatment is developed.
|
|
| Locked | Locked | Locked |
Therapeutics and diagnostic devices for diabetes and obesity are developed.
|
Detailed competitors of ValenTx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Valentx
Complete news archive for ValenTx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ValenTx
ValenTx was founded in 2002 and raised its 1st funding round 4 years after it was founded.
ValenTx is headquartered in Carpinteria, United States. It is registered at Carpinteria, California, United States.
ValenTx is a funded company, having raised a total of $48.74M across 5 funding rounds to date.
ValenTx, founded in 2002 in Carpinteria, United States, focuses on providing healthcare solutions, developing medical devices, obesity treatment, and endoluminal solutions. Provides an adjustable endoluminal bypass sleeve for obesity treatment. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
ValenTx's top competitors include GI Windows, EndObetes and Hangzhou Tongee Medical Technology.
ValenTx has 7 investors. Key investors include Medtronic, EDF Ventures, Kaiser Permanente Ventures, SV Health Investors, and Affinity Capital Management.